Capricor Therapeutics, Inc. (CAPR) - NASDAQ
From other sites
Company Description
Capricor Therapeutics, Inc. is a clinical stage biopharmaceutical company. It focuses on creating value through clinical development of innovative products for cardiovascular and metabolic disease. Capricor's lead product candidate consists of allogeneic cardiosphere-derived cells, or CDCs.... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States